New study explains loss of efficacy of common type 2 diabetes drug

Research

25/09/2025

Researchers from the UB, IDIBELL, Bellvitge Hospital and CIBERDEM provide an explanation for the loss of efficacy of sulphonylureas, one of the most common treatments for diabetes.

 

SAE telephone and face-to-face support during academic course:
Monday, Wednesday and Friday from 10 am to 2 pm, and Tuesday and Thursday from 10 am to 5 pm.
The timetable may change at Christmas, Easter week and during the summer.

To complete administrative procedures related to your academic activities: 
get in touch with the Secretary's Office for Students in your faculty or affiliated school.